Effect of once-yearly infusion of zoledronic acid 5 mg on spine and hip fracture reduction in postmenopausal women with osteoporosis: The HORIZON pivotal fracture trial.

被引：0
|
作者：
Black, D. M.
Boonen, S.
Cauley, J.
Delmas, P.
Eastell, R.
Reid, I.
Rosario-Jansen, T.
Caminis, J.
Zhang, J.
Hu, H.
Cummings, S.
机构：
[1] UCSF, San Francisco, CA USA
[2] Leuven Univ, Louvain, Belgium
[3] Univ Pittsburgh, Pittsburgh, PA USA
[4] Univ Lyon 1, F-69365 Lyon, France
[5] Univ Sheffield, Sheffield, S Yorkshire, England
[6] Univ Auckland, Auckland 1, New Zealand
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] UCSF, San Francisco, CA USA
[9] CPMC Res Inst, San Francisco, CA USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S305 / S305
页数：1
相关论文
共 50 条
  • [21] Once-yearly zoledronic acid in hip fracture prevention
    Demontiero, Oddom
    Duque, Gustavo
    CLINICAL INTERVENTIONS IN AGING, 2009, 4 : 153 - 164
  • [22] ONCE-YEARLY ZOLEDRONIC ACID 5 MG INFUSION FOR TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: EFFECTS ON FRACTURE INCIDENCE IN PATIENT SUBGROUPS FROM THE HORIZON-PFT STUDY
    Eastell, Richard
    Black, Dennis M.
    Boonen, Steven
    McLellan, Alastair R.
    Cummings, Steven R.
    Delmas, Pierre D.
    Palermo, Lisa
    Mesenbrink, Peter
    Cauley, Jane A.
    RHEUMATOLOGY, 2009, 48 : I105 - I105
  • [23] EFFECT OF ONCE-YEARLY ZOLEDRONIC ACID IN MEN AFTER RECENT HIP FRACTURE: RESULTS FROM HORIZON RECURRENT FRACTURE TRIAL
    Boonen, Steven
    Kaufmann, Jean-Marc
    Orwoll, Eric
    Magaziner, Jay
    Colon-Emeric, Cathleen
    Adachi, Rick
    Bucci-Rechtweg, Christina
    Haentjhens, Patrick
    Vanderschueren, Dirk
    Lyles, Kenneth
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 180 - 180
  • [24] EFFECT OF ONCE-YEARLY IV ZOLEDRONIC ACID IN MEN AFTER HIP FRACTURE: RESULTS FROM THE HORIZON-RECURRENT FRACTURE TRIAL
    Boonen, S.
    Magaziner, J.
    Lyles, K.
    Colon-Emeric, C.
    Adachi, J.
    Bucci-Rechtweg, C.
    Mesenbrink, P.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 84 - 84
  • [25] EFFECT OF ONCE-YEARLY IV ZOLEDRONIC ACID IN MEN AFTER HIP FRACTURE: RESULTS FROM THE HORIZON-RECURRENT FRACTURE TRIAL
    Boonen, S.
    Magaziner, J.
    Lyles, K. W.
    Dennison, E.
    Colon-Emeric, C.
    Adachi, J. D.
    Bucci-Rechtweg, C.
    Mesenbrink, P.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S271 - S272
  • [26] Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older
    Boonen, Steven
    Black, Dennis M.
    Colon-Emeric, Cathleen S.
    Eastell, Richard
    Magaziner, Jay S.
    Eriksen, Erik Fink
    Mesenbrink, Peter
    Haentjens, Patrick
    Lyles, Kenneth W.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 (02) : 292 - 299
  • [27] Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture
    Boonen, Steven
    Orwoll, Eric
    Magaziner, Jay
    Colon-Emeric, Cathleen S.
    Adachi, Jonathan D.
    Bucci-Rechtweg, Christina
    Haentjens, Patrick
    Kaufman, Jean-Marc
    Rizzoli, Rene
    Vanderschueren, Dirk
    Claessens, Frank
    Sermon, An
    Witvrouw, Richard
    Milisen, Koen
    Su, Guoqin
    Lyles, Kenneth W.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (11) : 2084 - 2090
  • [28] HORIZON-PIVOTAL FRACTURE TRIAL UNIQUE DESIGN OF A RANDOMIZED. PLACEBO-CONTROLLED TRIAL TO EXAMINE THE EFFECT OF ANNUAL INFUSION OF ZOLEDRONIC ACID (5 MG) ON HIP AND SPINE FRACTURE REDUCTION
    Black, D. M.
    Rosario-Jansen, T.
    Cauley, J. A.
    Mautalen, C. A.
    Reid, I. R.
    Caminis, J.
    Flood, M.
    Cummings, S. R.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S101 - S101
  • [29] Once-Yearly Zoledronic Acid and Days of Disability, Bed Rest, and Back Pain: Randomized, Controlled HORIZON Pivotal Fracture Trial
    Cauley, Jane A.
    Black, Dennis
    Boonen, Steven
    Cummings, Steven R.
    Mesenbrink, Peter
    Palermo, Lisa
    Man, Zulema
    Hadji, Peyman
    Reid, Ian R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (05) : 984 - 992
  • [30] Horizon-pivotal fracture trial: Unique design of a randomized, placebo-controlled trial to examine the effect of annual infusion of zoledronic acid (5 mg) on hip and spine fracture
    Black, DM
    Rosario-Jansen, T
    Delmas, PD
    Eastell, R
    Lau, EMC
    Boonen, S
    Caminis, J
    Flood, M
    Cummings, SR
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S99 - S99
12345